12- and 13-substituted ergoline derivatives having alpha.sub.2 -receptor-blocking effect

US4863929A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Gerhard Sauer · Berlin, DE
• Josef Heindl · Berlin, DE
• Gertrud Schroeder · Berlin, DE
• Helmut Wachtel · Berlin, DE

Key dates

• Filing date: Sep 19, 1986
• Grant date: Sep 5, 1989
• Expiry date: Sep 19, 2006

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F7/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel 12- and 13-substituted ergoline derivatives are suitable, e.g., as psychopharmaceuticals and for hypertension therapy.